Letters to the Editor
Vol. 89 No. 3 (2019)
Similar outcome of heart failure with reduced EF patients with and without atrial fibrillation: considerations from the ESC Heart Failure Long-Term Registry
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 15 March 2019
Accepted: 4 July 2019
Accepted: 4 July 2019
1301
Views
779
Downloads
Authors
Recently, transcatheter ablation of atrial fibrillation (AF) has been validated by international societal guidelines as a technique suitable for both treatment and secondary prevention of paroxysmal, persistent or long-lasting persistent AF in highly symptomatic patients in whom at least one antiarrhythmic drug had been tested.
Downloads
Download data is not yet available.
Citations
How to Cite
“Similar Outcome of Heart Failure With Reduced EF Patients With and Without Atrial Fibrillation: Considerations from the ESC Heart Failure Long-Term Registry”. 2019. Monaldi Archives for Chest Disease 89 (3). https://doi.org/10.4081/monaldi.2019.1061.